Virios Therapeutics Stock (NASDAQ: VIRI) stock price, news, charts, stock research, profile.
Open | $0.26 |
Close | $0.25 |
Volume / Avg. | 1.63M / 1.47M |
Day Range | 0.22 - 0.27 |
52 Wk Range | 0.16 - 2.20 |
Market Cap | $6.88M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 1.17% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Virios Therapeutics (NASDAQ:VIRI) through any online brokerage.
Other companies in Virios Therapeutics’s space includes: Addex Therapeutics (NASDAQ:ADXN), NuCana (NASDAQ:NCNA), AquaBounty Techs (NASDAQ:AQB), TransCode Therapeutics (NASDAQ:RNAZ) and Tonix Pharmaceuticals (NASDAQ:TNXP).
There is no analysis for Virios Therapeutics.
Virios Therapeutics has a consensus price target of $1.00.
The stock price for Virios Therapeutics (NASDAQ: VIRI) is $0.2479 last updated July 19, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Virios Therapeutics.
Virios Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Virios Therapeutics.
Virios Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.